Canadian Nuclear Isotope Council

CNIC Chair James Scongack shares why this council is so important for Canadians

On behalf of the CNIC team, Happy Holidays! We wish you all the very best and hope that you can find the time to relax and connect with those closest to you this holiday season.   We’ll be back in the new year with exciting plans for our work in 2025! Stay tuned!

While we often highlight their life-changing potential for cancer patients globally, isotopes aren't just for medical uses. They’re essential in industrial applications too!   They are used for radiography, material testing, and quality assurance. These applications ensure safety and reliability in various sectors and contribute significantly to Canada's economy. #Isotopes #CanadianIsotopeInnovation

It was a pleasure to attend the Symposium on Medical Isotopes in Vancouver last week organized by Canadian Medical Isotope Ecosystem and Canadian Nuclear Isotope Council. Great discussions and presentations!

As we approach the end of 2024, AtomVie Global Radiopharma (AtomVie) is reflecting on the remarkable progress and expansion within the radiopharmaceutical industry. This year has been defined by significant investments, high-impact partnerships, notable acquisitions, and positive clinical trial outcomes—highlighting the transformative potential of radiopharmaceuticals in patient care.   AtomVie is proud to continue playing a vital role in advancing this dynamic industry as trusted CDMO partner to innovators worldwide. Our new 72,300-square-foot facility, designed to scale production to more than 10 times our current capacity is equipped to support the development of pipeline assets, clinical and commercial manufacturing for our partners. This growth underscores our commitment to working with industry leaders globally to deliver high-quality radiopharmaceuticals that transform patients’ lives.   We have shared selected highlights and key market trends in the slides below - check them out and let us know what you observed in 2024 and where you see the industry going in the comments below!   #AtomVieGlobalRadiopharma #2024MarketTrends #Radiopharmaceuticals #IndustryGrowth #TransformingLives

Telix has completed the installation of two new cyclotrons at Telix Manufacturing Solutions (TMS) in Brussels South, Belgium, facilitating the production of radioisotopes and patient doses on-site from 2025. The installation of cyclotrons from GE HealthCare and IBA, along with ARTMS solid targetry, establishes TMS Brussels South as a major nuclear medicine production facility, which will serve as the Company’s primary manufacturing site for the EMEA region and beyond. One cyclotron will be dedicated to clinical and commercial supply, and the other to R&D, enabling TMS Brussels South to become a vital hub for manufacturing scale-up and production of next generation radiopharmaceuticals, including diagnostics and both alpha- and beta therapeutics. Commissioning of the cyclotrons is scheduled to begin in early 2025, with first commercial GMP production anticipated in H2 2025, subject to requisite audits and accreditation. Read more on our website here: https://bit.ly/3BB5HAl

As a co-lead of the Canadian Medical Isotope Ecosystem, CPDC was proud to have co-organized and sponsored the 1st Symposium on Medical Isotopes in Vancouver! Over 70 key stakeholders gathered to explore the future of medical isotopes, with highlights including innovative presentations, expert panels, and a tour of TRIUMF. The symposium fostered valuable discussions on overcoming challenges and accelerating growth in Canada’s medical isotope sector. Thank you to all participants and partners who made this event a success. We look forward to next years event! Canadian Nuclear Isotope Council TRIUMF Innovations Inc. Bruce Power #MedicalIsotopesSymposium24 #IsotopeInnovation #CPDC #CMIE

This afternoon we're excited to share some more photos from the 1st Annual CMIE-CNIC Symposium on Medical Isotopes in Vancouver, British Columbia. The symposium was a resounding success, bringing together over seventy key stakeholders from across Canada's medical isotope ecosystem for an engaging and insightful two-day experience. Thank you to everyone who joined us for these exciting conversations! Read more about the 1st Annual Symposium on Medical Isotopes here: https://lnkd.in/gHkDbAx5

#DYK nuclear energy saves lives? Nuclear isotopes, harvested from nuclear power reactors in Ontario are used to sterilize medical equipment, in medical imaging and more. https://bit.ly/4f4PC3t #nuclearenergy #nuclearisotopes Ontario Power Generation

We were excited to be featured in the Organization of Canadian Nuclear Industries 2024 Canadian Nuclear Year in Review! 2024 was an action-packed year of growth and impact for the CNIC, and we were glad to reflect on the year and join OCNI in recognizing the successes of our colleagues and partners across Canada's nuclear sector this year. You can read OCNI's 2024 Canadian Nuclear Year in Review here: https://lnkd.in/g2SyUzns